Go Pro
NASDAQ:LFVN

Lifevantage (LFVN) Stock Price, News & Analysis

Lifevantage logo
$6.76 +0.18 (+2.74%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$6.74 -0.01 (-0.22%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Lifevantage Stock (NASDAQ:LFVN)

Advanced

Key Stats

Today's Range
$6.58
$6.97
50-Day Range
$6.04
$10.70
52-Week Range
$3.90
$15.00
Volume
50,176 shs
Average Volume
90,710 shs
Market Capitalization
$85.28 million
P/E Ratio
15.02
Dividend Yield
2.96%
Price Target
$5.00
Consensus Rating
Hold

Company Overview

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market. The company’s research and development efforts focus on leveraging cellular biology insights to create products that support antioxidant activity and overall well-being. Its sales force operates on a multi-level marketing framework, earning commissions through personal and team retail sales.

LifeVantage maintains a global presence, with active markets in North America, Europe, Asia-Pacific and South Africa. Through this international footprint, the company serves health-conscious consumers across more than 30 markets. Distributors utilize online platforms and in-person presentations to educate customers about the science behind each product and to build a recurring revenue base.

Governed by a board of directors and a senior management team, LifeVantage places emphasis on product innovation, regulatory compliance and distributor training. The company continues to explore partnerships and clinical collaborations aimed at validating its formulations and expanding its reach within the competitive health and wellness industry.

AI Generated. May Contain Errors.

Lifevantage Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

LFVN MarketRank™: 

Lifevantage scored higher than 41% of companies evaluated by MarketBeat, and ranked 123rd out of 172 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Lifevantage has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

  • Downside Risk

    Lifevantage has a consensus price target of $5.00, representing about 26.0% downside from its current price of $6.76.

  • Amount of Analyst Coverage

    Lifevantage has only been the subject of 1 research reports in the past 90 days.

  • Read more about Lifevantage's stock forecast and price target.
  • Earnings Growth

    Earnings for Lifevantage are expected to grow by 8.33% in the coming year, from $0.60 to $0.65 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Lifevantage is 15.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.61.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Lifevantage is 15.02, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 14.12.

  • Price to Book Value per Share Ratio

    Lifevantage has a P/B Ratio of 2.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Lifevantage's valuation and earnings.
  • Percentage of Shares Shorted

    14.90% of the float of Lifevantage has been sold short.
  • Short Interest Ratio / Days to Cover

    Lifevantage has a short interest ratio ("days to cover") of 7.96.
  • Change versus previous month

    Short interest in Lifevantage has recently decreased by 21.83%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Lifevantage pays a meaningful dividend of 3.00%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Lifevantage has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Lifevantage is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Lifevantage will have a dividend payout ratio of 30.77% next year. This indicates that Lifevantage will be able to sustain or increase its dividend.

  • Read more about Lifevantage's dividend.
  • News Sentiment

    Lifevantage has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Lifevantage this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for LFVN on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Lifevantage insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    21.95% of the stock of Lifevantage is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    35.32% of the stock of Lifevantage is held by institutions.

  • Read more about Lifevantage's insider trading history.
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifevantage and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LFVN Stock News Headlines

A $5 stock inside Kennedy Space Center?
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Kennedy Space Center, just steps from SpaceX and Blue Origin. Under a special operating agreement, the company uses the multi-billion-dollar federal facility for just 500 dollars. Its launch system reportedly cuts fuel costs by 90 percent and enables multiple launches in a single day. The stock currently trades under 5 dollars and is approaching a key licensing milestone most retail investors have not yet noticed.tc pixel
Lifevantage (LFVN) Stock Forecast & Price Target
LFVN Share News Today
See More Headlines

LFVN Stock Analysis - Frequently Asked Questions

Lifevantage's stock was trading at $6.16 at the beginning of the year. Since then, LFVN shares have increased by 9.7% and is now trading at $6.76.

Lifevantage Corporation (NASDAQ:LFVN) released its earnings results on Wednesday, May, 6th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.16 by $0.04. The firm had revenue of $43.72 million for the quarter, compared to the consensus estimate of $47.77 million. Lifevantage had a net margin of 2.94% and a trailing twelve-month return on equity of 23.89%.
Read the conference call transcript
.

Lifevantage's top institutional investors include Bank of New York Mellon Corp (0.10%). Insiders that own company stock include Darwin Lewis, Carl Aure, Raymond B Greer, Judd Dayton, Garry Paul Mauro and Michael A Beindorff.
View institutional ownership trends
.

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lifevantage investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/06/2026
Record date for 6/15 Dividend
6/01/2026
Ex-Dividend for 6/15 Dividend
6/01/2026
Dividend Payable
6/15/2026
Today
8/08/2026
Next Earnings (Estimated)
9/03/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Personal Care Products
Sub-Industry
Personal Care Products
Current Symbol
NASDAQ:LFVN
CIK
849146
Employees
260
Year Founded
1988

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
-26.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.45
Trailing P/E Ratio
15.02
Forward P/E Ratio
11.27
P/E Growth
N/A
Net Income
$9.81 million
Net Margins
2.94%
Pretax Margin
3.46%
Return on Equity
23.89%
Return on Assets
12.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.96
Quick Ratio
1.04

Sales & Book Value

Annual Sales
$195.32 million
Price / Sales
0.44
Cash Flow
$1.13 per share
Price / Cash Flow
5.99
Book Value
$2.75 per share
Price / Book
2.46

Miscellaneous

Outstanding Shares
12,616,000
Free Float
9,847,000
Market Cap
$85.28 million
Optionable
Optionable
Beta
0.72

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:LFVN) was last updated on 8/8/2026 by MarketBeat.com Staff.
From Our Partners